Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

May 2031 10

  1. Primary completion Renal Efficacy and Safety of the Novel Oral Small-Molecule GLP-1RA HRS-7535 Evaluated in Participants With Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07625774

  2. Primary completion Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07795593

  3. Primary completion An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07543120

  4. Primary completion A Phase III Study To Evaluate the Efficacy And Safety Of HRS9531 In Participants With Atherosclerotic Cardiovascular Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07551492

  5. Primary completion Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07613099

  6. Study completion Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04864145

June 2031 19

  1. Study completion Clinical Study of Endocardial Myocardial Biopsy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05718128

  2. Primary completion Clinical Study of Endocardial Myocardial Biopsy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05718128

  3. Primary completion Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06964464

  4. Primary completion Net Clinical Benefit of Edoxaban Versus Apixaban in Patients With Atrial Fibrillation and Coronary Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07753200

  5. Study completion COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02744677

  6. Study completion Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02845531

  7. Study completion Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07091682

  8. Study completion SGLT2 Inhibitor in Patients With Asymptomatic Moderate or Severe Aortic Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07944066

  9. Primary completion SGLT2 Inhibitor in Patients With Asymptomatic Moderate or Severe Aortic Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07944066

  10. Study completion Physiological vs Right Ventricular Pacing Outcome Trial Evaluated for bradyCardia Treatment (PROTECT-HF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05815745

  11. Primary completion Physiological vs Right Ventricular Pacing Outcome Trial Evaluated for bradyCardia Treatment (PROTECT-HF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05815745

  12. Study completion Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06858319

  13. Primary completion Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06858319

  14. Study completion A Phase III Study To Evaluate the Efficacy And Safety Of HRS9531 In Participants With Atherosclerotic Cardiovascular Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07551492

  15. Study completion Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03706833

  16. Study completion Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06520774

  17. Study completion Study on the Aortic Arch Single Branch Stent Graft System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06915545

  18. Study completion Comparison of Different Pulsed Field Ablation Catheters in Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07036965

  19. Primary completion MIRACLE-T2D Montelukast Intervention for Renal, Cardiovascular and Eye Health in Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07685886

July 2031 17

  1. Study completion Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06964464

  2. Primary completion Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07684742

  3. Study completion Naloxone for In-Hospital Cardiac Arrest Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07806565

  4. Primary completion Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05293080

  5. Study completion AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06029660

  6. Study completion Cilostazol for Prevention of Recurrent Stroke Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07174414

  7. Primary completion Cilostazol for Prevention of Recurrent Stroke Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07174414

  8. Study completion Renal Efficacy and Safety of the Novel Oral Small-Molecule GLP-1RA HRS-7535 Evaluated in Participants With Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07625774

  9. Study completion The NICE-PAD II Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07782671

  10. Study completion Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07795593

  11. Study completion Ticagrelor for Inflammation and Cardiovascular Risk in Patients With Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07911124

  12. Study completion PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05387954

  13. Primary completion PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05387954

  14. Study completion Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07493304

  15. Primary completion Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07493304

  16. Primary completion Penicillin to Prevent Early Rheumatic Heart Disease in School-Aged Children Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07798232

August 2031 9

  1. Study completion Eplerenone in Patients Undergoing REnal Transplant (EPURE TRANSPLANT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02490904

  2. Study completion A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07241390

  3. Primary completion A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07241390

  4. Study completion A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07527299

  5. Study completion TTVR Early Feasibility Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04433065

  6. Study completion Cilostazol vs. Aspirin in Acute Non-cardioembolic Stroke With Cerebral mIcrobleeds Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06530537

  7. Primary completion Cilostazol vs. Aspirin in Acute Non-cardioembolic Stroke With Cerebral mIcrobleeds Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06530537

  8. Study completion Combined Mitral and Tricuspid Versus Isolated Mitral Transcatheter Edge-to-Edge Repair for Mitral Regurgitation With Tricuspid Regurgitation (DUAL-TEER Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07349888

  9. Study completion MIRACLE-T2D Montelukast Intervention for Renal, Cardiovascular and Eye Health in Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07685886

September 2031 11

  1. Study completion A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04671771

  2. Study completion GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06827990

  3. Study completion Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05293080

  4. Study completion SELUTION 4 De Novo Small Vessel IDE Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05946629

  5. Study completion Multiparametric Assessment of Maternal Vascular Function in the Prediction of Hypertensive Disorders of Pregnancy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05999851

  6. Study completion ATLAS (AltaValve) Pivotal Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06465745

  7. Study completion Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06779630

  8. Primary completion Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07321899

  9. Primary completion The TRICURE US IDE Pivotal Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07528326

  10. Study completion Capital Offload-Shock Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07756801

  11. Primary completion Inter-Limb Transfer in Acute Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07822633

October 2031 8

  1. Primary completion Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06563895

  2. Study completion The ENCIRCLE Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04153292

  3. Study completion OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And Lipoprotein(a) Reduction to Prevent First Major Cardiovascular Events Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07136012

  4. Primary completion OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And Lipoprotein(a) Reduction to Prevent First Major Cardiovascular Events Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07136012

  5. Study completion Parent Artery Reconstruction for Small Unruptured Cerebral Aneurusms Using Flow DiverTers: a Multicenter Randomized Trial(PARAT-MT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06600997

  6. Primary completion Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07116928

  7. Primary completion REstoring Flow by REvascularization With Submaximal Angioplasty in Hemodynamic IntraCranial Atherosclerotic Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03729817

November 2031 6

  1. Primary completion Oral Anticoagulation in Patients With Prior Deep Intracerebral Hemorrhage, Atrial Fibrillation, and Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07609654

  2. Study completion Zenith® Fenestrated+ Clinical Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04875429

  3. Study completion MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06271590

  4. Primary completion Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis 2 (SAFE-D2) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07779746

  5. Study completion An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07543120

  6. Study completion Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06008756

December 2031 26

  1. Primary completion Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01524211

  2. Study completion The CONFORM Pivotal Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05147792

  3. Primary completion Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05478304

  4. Study completion The STOP-MED CTRCD Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06183437

  5. Study completion A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07285655

  6. Study completion Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07454707

  7. Primary completion Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07454707

  8. Study completion Safety and Efficacy of the AbsnowTM II Absorbable Atrial Septal Defect Closure System for Atrial Septal Defect Closure Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07529028

  9. Study completion Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07611747

  10. Study completion Evaluation of the Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07714876

  11. Study completion Leveraging Telemedicine to Improve Guideline-Directed Medical Therapy Use and Outcomes Among Rural Patients With Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07946679

  12. Primary completion Leveraging Telemedicine to Improve Guideline-Directed Medical Therapy Use and Outcomes Among Rural Patients With Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07946679

  13. Study completion Expanded Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04029363

  14. Study completion TARGET Study: Safety and Performance of the Cardiovalve TR Replacement System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05486832

  15. Primary completion Catheter Ablation vs Conservative Care in Elderly Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07424690

  16. Study completion Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07116928

  17. Study completion Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04097145

  18. Study completion Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05845489

  19. Study completion Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07052799

  20. Study completion Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07288749

  21. Primary completion Digital Screening for Atrial Fibrillation to Prevent Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07684053

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study completion Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind. Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03389100

  2. Primary completion Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind. Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03389100

  3. Primary completion Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03706833

  4. Study completion AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03732794

  5. Study completion Cardiovascular Magnetic Resonance GUIDEd Insertion of Implantable Cardiac Defibrillator in Dilated CardioMyopathy Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03993730

  6. Primary completion Cardiovascular Magnetic Resonance GUIDEd Insertion of Implantable Cardiac Defibrillator in Dilated CardioMyopathy Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03993730

  7. Study completion SyncAV Post-Market Trial Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04100148

  8. Study completion Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04242134

  9. Study completion Left Atrial Posterior Wall Additional Isolation for Persistent Atrial Fibrillation Trial Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04405258

  10. Study completion Contribution of Optical Coherence Tomography in the Endovascular Treatment of Femoral Occlusions Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04434586

  11. Primary completion Contribution of Optical Coherence Tomography in the Endovascular Treatment of Femoral Occlusions Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04434586

  12. Study completion THE TRAVEL TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04436653

  13. Primary completion THE TRAVEL TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04436653

  14. Primary completion Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04451044

  15. Study completion Early Antiplatelet Therapy After Hemorrhagic Infarction in Acute Ischemic Stroke Treated With Intravenous Thrombolysis (HITs) Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04624295

  16. Study completion Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04680442

  17. Study completion The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04728516

  18. Primary completion The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04728516

  19. Primary completion Clinical Evaluation of the Free Margin Cusp Sizer (CALIBRATE) Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04797572

  20. Study completion The Effects of Sacubitril-Valsartan vs Enalapril on Left Ventricular Remodeling in ST-elevation Myocardial Infarction Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04912167

  21. Primary completion Morning Versus Bedtime Dosing of Antihypertensive Medication Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05089448

  22. Study completion EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial) Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05151172

  23. Study completion Home-based Remote Monitoring Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05295303

  24. Study completion SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05345327

  25. Primary completion SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05345327

  26. Study completion DEX vs SEVO in Congenital Heart Surgery Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05369949

  27. Primary completion INSIGHTFUL-FFR Clinical Trial Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05437900

  28. Study completion Treatment Preventive for Pre-eclampsia by Acetylsalicylic Acid in Women Who Underwent Frozen Embryo Transfer Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05460416

  29. Study completion CardioPulmonary Resuscitation With Argon (CPAr) Trial Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05482945

  30. Study completion The Effect of Intravenous Iron Therapy and Erythropoiesis-stimulation Agent Combination on Renal Transplant Outcomes Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05719376

  31. Primary completion Tongxinluo Capsule in the Treatment of Cerebral Small Vessel Disease-A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study(TOPS-CSVD) Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06061692

  32. Study completion To Evaluate the Safety and Effectiveness of Flow Modulation Device for Intracranial Aneurysms Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06158750

  33. Primary completion Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrillation Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06187311

  34. Study completion A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06254014

  35. Primary completion Advapro Coronary Stent System in Coronary Artery Diseased Patients. Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06300268

  36. Study completion The Efficacy of Enavogliflozin in Heart Failure With Preserved Ejection Fraction Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06350487

  37. Study completion RESTORE Imaging: an OCT-IVUS Imaging Substudy of RESTORE Trial Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06449274

  38. Primary completion RESTORE Imaging: an OCT-IVUS Imaging Substudy of RESTORE Trial Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06449274

  39. Primary completion Telerehabilitation of Balance Clinical and Economic Decision Support System Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06534164

  40. Study completion Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06587347

  41. Primary completion Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06587347

  42. Study completion Fufang Congrong Yizhi Capsules (FCYC) of Cognitive Impairment After Intracerebral Hemorrhage Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06673602

  43. Primary completion Fufang Congrong Yizhi Capsules (FCYC) of Cognitive Impairment After Intracerebral Hemorrhage Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06673602

  44. Primary completion Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06750341

  45. Primary completion Efficacy and Safety of Early Initiation of Vericiguat in Heart Failure After Acute Myocardial Infarction Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06812546

  46. Study completion Efficacy and Safety of Tirzepatide for Weight Management Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06918405

  47. Primary completion Efficacy and Safety of Tirzepatide for Weight Management Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06918405

  48. Study completion Coronary Aspiration Catheter Clinical Trial Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06951724

  49. Study completion Nudge-Based Shared Decision Making and Self-Management in Type 2 Diabetes: A Randomized Trial Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07129915

  50. Primary completion Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07225101

  51. Study completion Evaluating the Safety and Effectiveness of a Vascular Interventional Robotic System in Assisting With Percutaneous Coronary Intervention Procedures: A Prospective, Multicenter, Randomized Controlled Clinical Trial Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07233317

  52. Primary completion Evaluating the Safety and Effectiveness of a Vascular Interventional Robotic System in Assisting With Percutaneous Coronary Intervention Procedures: A Prospective, Multicenter, Randomized Controlled Clinical Trial Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07233317

  53. Primary completion The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07272343

  54. Study completion The Coronary Sinus Balloon Pump in STEMI Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07354035

  55. Study completion Atrial Fibrillation TRIal of Left Atrial Appendage Closure Using Seralene Hemostatic Suture Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07360899

  56. Study completion Inhibition of Late Sodium Current (INa) to Prevent Coronary MICROvascular Dysfunction in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Disease: INaMICRON Study Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07380919

  57. Primary completion Inhibition of Late Sodium Current (INa) to Prevent Coronary MICROvascular Dysfunction in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Disease: INaMICRON Study Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07380919

  58. Study start Impact of Low Dose Epinephrine in the Management of Out-of-hospital Cardiac Arrest on Neurological Outcome Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07442071

  59. Study start Use of the Methoxyflurane as Pain-killer in the Prehospital Management of Acute Myocardial Infarction Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07445737

  60. Study start SMART-VERAPAF: Self-MAnagement and Random Therapy With VERApamil or Metoprolol in Paroxysmal Atrial Fibrillation Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07445789

  61. Study completion Metformin, Empagliflozin With Sitagliptin vs Linagliptin in Type 2 Diabetes Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07452913

  62. Study start Chocolate Balloon vs Standard Balloon Angioplasty Before Drug-Coated Balloon Treatment for Femoropopliteal Artery Narrowing or Blockage Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07471087

  63. Study start Role of Neuroinflammation and Blood-Brain Barrier Breakdown in Intracerebral Hemorrhage. Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07583147

  64. Study start To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes Mellitus Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07619833

  65. Study start SURE-HF: Urinary Sodium-Guided Diuretic Therapy in Heart Failure Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07631780

  66. Study start A Study to Determine if BHV-1400 is Effective and Safe in Adults With IgA Nephropathy Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07642050

  67. Study start Platelet Aggregation Function-Guided De-Escalation Antiplatelet Therapy in Patients With Acute Ischemic Stroke Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07644234

  68. Study start Evaluating Bu Yang Huanwu Decoction For Early Diabetic Vascular Disease Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07658807

  69. Study completion Inspiratory Muscle Strength Training in Chronic Kidney Disease Registry record

    Expected 2026-07-01; that period ended on 2026-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04911491

  70. Primary completion Inspiratory Muscle Strength Training in Chronic Kidney Disease Registry record

    Expected 2026-07-01; that period ended on 2026-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04911491

  71. Study completion Efficacy of Endothelin Receptor Antagonism in Coronary Artery Spasm Registry record

    Expected 2026-07-01; that period ended on 2026-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06432452

  72. Primary completion IcoSApent ethyL to Slow Down Aortic VAlve Stenosis proGrEssion Registry record

    Expected 2026-07-01; that period ended on 2026-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06466278

  73. Primary completion Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke Registry record

    Expected 2026-07-01; that period ended on 2026-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06653348

  74. Study completion Use of App for Stroke Assessment VS Standard Level of Care During Prehospital Stroke Assessment Registry record

    Expected 2026-07-01; that period ended on 2026-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06672757

  75. Study completion Tranexamic Acid with Intensive Blood Pressure Management in Ultra-Early Intracerebral Hemorrhage Registry record

    Expected 2026-07-01; that period ended on 2026-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06760078

  76. Primary completion iTBS for Acute Ischemic Stroke After Thrombectomy Registry record

    Expected 2026-07-01; that period ended on 2026-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06941961

  77. Primary completion Comparing Super High-flux and High-flux Dialyzer Performance Among Hemodialysis Patient With Sepsis : a Randomized Control Trial Registry record

    Expected 2026-07-01; that period ended on 2026-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06989892

  78. Primary completion BM Shockwave Devices Clinical Study in Coronary Calcified Lesions Registry record

    Expected 2026-07-01; that period ended on 2026-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07010094

  79. Study completion The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes Registry record

    Expected 2026-07-01; that period ended on 2026-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07272343

  80. Primary completion Acetyl-leucine in Post-stroke Ataxia Registry record

    Expected 2026-07-01; that period ended on 2026-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07275749

  81. Study start kTMP in Chronic Stroke Registry record

    Expected 2026-07-01; that period ended on 2026-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07277595

  82. Study completion Comparison of 7-Day ECG Patches Registry record

    Expected 2026-07-01; that period ended on 2026-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07564349

  83. Study start Clinical Study of Chinese Herbal Compound Qidan Xiaoke Granules in Patients After Coronary Revascularization Registry record

    Expected 2026-07-01; that period ended on 2026-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07616544

  84. Study start In-Hospital Wearable-Based Monitoring Versus Standard Care in Cardiovascular Disease (INSPIRE) Registry record

    Expected 2026-07-01; that period ended on 2026-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07622485

  85. Study start A Post-Marketing Clinical Trial of Pemafibrate in Patients with Hypercholesterolemia and Inadequate Response to Statins Registry record

    Expected 2026-07-01; that period ended on 2026-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07634484

  86. Study start Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease Registry record

    Expected 2026-07-01; that period ended on 2026-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07667517

  87. Study start Efficacy of Verciguat in TR and RV Failure Registry record

    Expected 2026-07-01; that period ended on 2026-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07668739

  88. Study start A Randomized Trial of Carotid Artery Stenting With Balloon Guide Catheter Registry record

    Expected 2026-07-01; that period ended on 2026-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07678164

  89. Study start Sublingual Edaravone Dexborneol for Inter-hospital Transfer Acute Ischemic Stroke (SLEDAIS) Registry record

    Expected 2026-07-01; that period ended on 2026-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07682922

  90. Study start Ciprofol vs Propofol for Hemodynamic Stability in Patients Having General Anesthesia for Endovascular Thrombectomy After Ischemic Stroke Registry record

    Expected 2026-07-01; that period ended on 2026-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07696208

  91. Study start Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors With Statin for ACS Patients Registry record

    Expected 2026-07-01; that period ended on 2026-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07736313

  92. Study start A Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential Hypertension Registry record

    Expected 2026-07-06; that period ended on 2026-07-06.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07660796

  93. Study start PulseMagic™ TrueForce™ PAF NMPA Study Registry record

    Expected 2026-07-10; that period ended on 2026-07-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07720557

  94. Primary completion Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI Registry record

    Expected 2026-07-11; that period ended on 2026-07-11.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04695106

  95. Study start HeartMate App-Based Remote Monitoring for Cardiovascular Risk Factor Management Registry record

    Expected 2026-07-14; that period ended on 2026-07-14.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07721584

  96. Study completion Human-like Robotic Controllers for Enhanced Motor Learning Registry record

    Expected 2026-07-15; that period ended on 2026-07-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04578665

  97. Primary completion Human-like Robotic Controllers for Enhanced Motor Learning Registry record

    Expected 2026-07-15; that period ended on 2026-07-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04578665

  98. Study completion Muscle Coordination-Based Feedback for Stroke Rehabilitation Registry record

    Expected 2026-07-15; that period ended on 2026-07-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06099444

  99. Primary completion Muscle Coordination-Based Feedback for Stroke Rehabilitation Registry record

    Expected 2026-07-15; that period ended on 2026-07-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06099444